NCT Number: NCT01799824
Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis
The purpose of this study is to confirm the effect of ANT-1403 in the treatment of primary axillary hyperhidrosis.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Miami, Florida, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- ages 18 - 70 years of age
- diagnosis of moderate to severe primary axillary hyperhidrosis
- ≥50 mg of sweat production/axilla in 5 minutes as measured gravimetrically
- HDSS score of ≥3
Exclusion criteria
- diagnosis of secondary hyperhidrosis
- skin affliction in the axilla requiring medical treatment
- 20% aluminum hydrochloride, e.g. Drysol®, in 2 weeks prior of Baseline
- oral anticholinergic treatment
- botulinum toxin treatment in the prior 9 months
- history of surgery for axillary hyperhidrosis
- present or history of neuromuscular disease
- female subjects who are pregnant or are nursing a child
Treatment and study plan
Placebo
BiologicalPrimary outcomes
-
HDSS
Time frame: Week 8
Secondary outcomes
-
GSP
Time frame: Week 8
Sponsors and collaborators
Lead sponsor
Anterios Inc.
Industry
Registry information
Official study title
Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis in Adults
Important dates
- Study start
- 2013
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Feb 27, 2013
- Registry last updated
- Dec 10, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis
NCT05863104
Hyperhidrosis, Primary Axillary Hyperhidrosis
Mahlow, Germany
View Trial DetailsEvaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
NCT04599907
Primary Axillary Hyperhidrosis
Encinitas, California, United States
View Trial DetailsA Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis
NCT03627468
Primary Axillary Hyperhidrosis
Mobile, Alabama, United States
View Trial DetailsAssessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.
NCT03658616
Hyperhidrosis, Primary Axillary Hyperhidrosis
Kiel, Germany
View Trial Details